HEALTHCBS NEWS
How an experimental weight-loss drug is being openly promoted by physicians
Doctors are prescribing an experimental weight-loss drug not yet approved by the FDA, which has gained viral attention on social media. A physician questioned the delay in its approval, asking, 'Why are we waiting?'
Related Signal
Adjacent reporting
- New weight-loss drug Retatrutide showing stronger results than current options
- Revolutionary Wegovy Pill weight-loss drug set to be approved for use in Britain 'within days' - and it will be cheaper than injections
- People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says
- FDA asks Lilly for more safety data on weight loss pill Foundayo
- Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
- STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more